• Dendritic Cell Vaccine in Immunotherapy Triple Combo Seen to Boost Immune Response to Myeloma in Early Study
  • Ninlaro Maintenance Therapy Fares Well in Phase 3 Multiple Myeloma Trial
  • Early Relapse in Multiple Myeloma Linked to Greater Economic Burden in US
  • Twice‐weekly Ninlaro Combo Improves Outcomes in Newly Diagnosed Myeloma Patients, Trial Shows
  • Kyprolis Label to Include Positive Data of Aspire Trial in Advanced Multiple Myeloma Patients
  • Advanced Blood Sample Analysis Could Be Better Than Bone Marrow Biopsies, Study Shows
  • Empliciti Triple Combo Delays Disease Progression in Advanced Myeloma Patients, Phase 2 Trial Data Show
  • Trial of Virus Combo to Treat Multiple Myeloma Adding Keytruda to Mix for Patient Group
  • Mutations in Noncoding Regions of Human Genome Also Cause Cancer, Study Shows
  • Advanced Myeloma Patients Responding to Selinexor Plus Standard Therapies in Trial, Data Show
  • Trillium Doses First Patient with TTI-622, a Candidate for Treating Myeloma, Lymphoma
  • Companies Collaborating to Use ClonoSEQ Assay in Multiple Myeloma Trials Testing Isatuximab